Healthcare Pharmaceutical Biotech

Europe Rejects Hemp, Marijuana CBD Safety - As U.S. Court Weighs Halting Medicare CMS Program Exposing Seniors To Unproven Products

May 5, 2026 6:00 AM

A federal judge is now deciding whether to halt a controversial Medicare linked hemp, marijuana CBD program-just as Europe's top scientific authority has delivered a stunning conclusion: It cannot confirm that a leading CBD product is safe for human consumption. The finding, issued by the European Food Safety Authority (EFSA)-widely regarded as the European equivalent of the U.S. Food and Drug Administration directly challenges the scientific...

Read more

AlzeCure Publishes its Interim Report for January – March 2026

May 5, 2026 2:20 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6) today announced that its interim report for the period January - March 2026 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/ "During the first quarter of 2026, our focus was on preparing the Phase II study in Alzheimer's patients with NeuroRestore ACD856, for which we were awarded a grant of EUR 2.5 million from the European Innovation...

Read more

GL Control Reviewed: Don't Buy Your Liquid Blood Sugar Supplements Before Reading This GlycoBalance Cascade Report First!

May 4, 2026 8:15 PM

This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. GL Control is a sublingual liquid supplement marketed for daily support of healthy blood sugar already within the normal range, built on six botanical ingredients and a 60-day money-back guarantee. This independent review walks through what the formula is, what the brand claims, what the offer looks like, and the...

Read more

Avant Brands Announces Voting Results from Its 2026 Annual General and Special Meeting of Shareholders

May 4, 2026 5:55 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce the voting results from its annual general and special meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") held on May 4, 2026. A total of 4,135,344 common shares were represented in person or by proxy at the Meeting, representing 27.85% of the total issued and outstanding common shares of the Company. The complete...

Read more

Medical Component Specialists to Support Advanced Catheter Innovation at The Catheter R&D Masterclass in Ireland

May 4, 2026 3:30 PM

Medical Component Specialists (MCS), a premier manufacturer of precision medical components, today announced its participation as a supporting organization at The Catheter R&D Masterclass. Hosted by Eyedea Medtech, the highly anticipated event will take place May 28-29, 2026, at the Prototyping and Education Facility in Westport, Mayo, Ireland. The Catheter Systems Lab is an exclusive, dual-purpose educational program designed for senior...

Read more

Pharmacists Mutual Advances Strategic Growth Initiative Through Collaboration with Positive Physicians

May 4, 2026 2:55 PM

Pharmacists Mutual Insurance Group ("Pharmacists Mutual") today announced a strategic collaboration with Positive Physicians Insurance Company ("Positive Physicians"), further advancing the Company's long-term growth strategy within the healthcare professional liability market. This collaboration represents a deliberate step in expanding Pharmacists Mutual's professional liability capabilities through alignment with a highly focused and...

Read more

Philip Ashton-Rickardt Calls for Greater Focus on Innovation in Neurodegenerative Disease Treatment

May 4, 2026 2:50 PM

Philip Ashton-Rickardt, Managing Director and Chief Scientific Officer at BE Therapeutics, is speaking out about the urgent need for stronger awareness, sustained effort, and innovation in the fight against neurodegenerative diseases such as ALS and multiple sclerosis. With decades of experience across academia and biotech, Ashton-Rickardt is calling on scientists, entrepreneurs, and individuals alike to take a more active role in supporting...

Read more

Alliant Health Solutions Awarded Multiple CMS ESRD Network Contracts, Expanding Impact Across Eight States

May 4, 2026 11:15 AM

Alliant Health Solutions (AHS) announced it has been awarded new End Stage Renal Disease (ESRD) Network contracts by the Centers for Medicare & Medicaid Services (CMS) for Networks 7, 8, 13, and 14. This significant achievement expands Alliant's footprint across eight states: Florida, Alabama, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. These awards build on Alliant's established leadership in ESRD Networks 8 and 14,...

Read more

Encision Inc. Announces Halt of Stock Trading

May 4, 2026 10:25 AM

Encision Inc. (OTC Pink:ECIA), a medical device company that owns patented Active Electrode Monitoring (AEM®) technology designed to prevent dangerous stray energy burns in minimally invasive surgery, today announced that trading in its common stock has been halted. The halt in trading results from the Company's filing of a Form 15 with the Securities and Exchange Commission ("SEC") to voluntarily deregister its common stock under Section 12(g)...

Read more

Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2026

May 4, 2026 10:10 AM

Ascelia Pharma (STO:ACE) - Today, on 4 May 2026, an annual general meeting was held in Ascelia Pharma AB. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes, except as set out below. Resolution on adoption of accounts and allocation of the company's result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income...

Read more

Advanced Chiropractic Equipment & Seminars Announces Venue Change for May 2026 Postgraduate Seminar in Houston

May 4, 2026 10:00 AM

Advanced Chiropractic Equipment & Seminars has announced a venue change for its upcoming Professional Postgraduate Education Seminar, scheduled to begin on May 1, 2026, in the Houston area. The seminar will now be held at the organisation's home office located in the Woodlands/Tomball area. This transition is designed to enhance the learning experience by offering more personalised, one-on-one professional training and certification...

Read more

Xcelerate Announces Agreements with Tanzanian Medical Professionals

May 4, 2026 9:25 AM

Xcelerate Inc. (OTCQB:XCRT) today announced that its majority-owned subsidiary, AfiyaSasa Africa LLC, has entered into a consulting agreement with Tanzanian medical doctor Dr. Desire Ruhinda to support the next phase of the Company's AfiyaSasa Africa initiative, while also confirming a May on-site R&D engagement led by its Chief Science Officer, Dr. Anja Glisovic. The agreement with Dr. Ruhinda marks a transition from strategic planning to...

Read more

Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health

May 4, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the planned launch of Neonorm Dog, a new extension of the Company's Neonorm franchise for companion animals. Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription product intended to support normal stool formation, gut hydration, and bowel health in dogs. The Neonorm franchise currently includes Neonorm Foal and Neonorm Calf, plant-based products...

Read more

NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA

May 4, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that its clinical stage, broad-spectrum, antiviral drug NV-387 has been granted an "Orphan Drug Designation" (ODD) by the US FDA Office of Orphan Products Development (OOPD). The...

Read more

TailorMed and Flatiron Health Partner to Expand Medication Access and Support Across Oncology Care

May 4, 2026 8:08 AM

TailorMed, the leading medication success platform, today announced a new partnership with Flatiron Health to offer access to comprehensive medication support across Flatiron's network of oncology providers. Through this collaboration, TailorMed becomes part of the Flatiron Vendor Network, enabling practices to more easily connect patients to financial assistance, support programs, and adherence resources throughout the medication journey....

Read more

CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing

May 4, 2026 7:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, announced today that it has entered into securities purchase agreements for a private placement financing that is expected to result in gross proceeds of approximately $22.5 million to the Company, before placement agent fees and offering expenses. The private...

Read more

Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall

May 4, 2026 1:50 AM

Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the nomination of a small molecule preclinical development candidate (PDC) from its multi‑target drug discovery alliance in medical dermatology with Almirall S.A. The program is aimed at developing novel treatments for immune‑mediated inflammatory skin diseases with high unmet medical need. The nomination marks an important achievement for the collaboration, with the joint team...

Read more

CMS EXPOSED: The "Workaround Doctrine" - How Matt Zorn's Legal CMS Hemp Strategy Undermines the FDA

May 3, 2026 11:30 AM

A major federal lawsuit now pending in the U.S. District Court for the District of Columbia is raising urgent questions about whether cannabinoid products can enter Medicare connected healthcare environments before they are proven safe and effective through the federal drug approval process. At the center of the dispute is: Smart Approaches to Marijuana (SAM), et al. v. Robert F. Kennedy Jr., et al. Case No. 1:26-cv-01081 (D.D.C.) The case...

Read more

Memopryl Reviews: Truth Behind Memopryl Cognitive Enhancement Supplement Before You Order in 2026

May 2, 2026 3:45 PM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new dietary supplement, especially if you take prescription medications, are pregnant or nursing, or have existing health conditions. This article contains affiliate links. If you click these links and make a purchase, a commission may be earned at no additional cost to you....

Read more

Glucolyn Reviewed: Don't Buy Your Next Blood Sugar Supplements Before Reading This Latest Report First!

May 2, 2026 3:15 PM

Disclaimers: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new dietary supplement, especially if you have a pre-existing condition, take medications, or are pregnant or nursing. This article contains affiliate links. If you click on these links and make a purchase, a commission may be earned at no additional cost to you. This...

Read more